Myristoyltransferase and calcineurin: Novel molecular therapeutic target for epilepsy

Progress in Neurobiology

Volumn 84, Issue 1, 2008, Pages 77-84

  Lakshmikuttyamma, Ashakumary ^a   Selvakumar, Ponniah ^a   Tuchek, John ^a   Sharma, Rajendra K ^a  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

Author keywords

Apoptotic factors; Calcineurin; Calmodulin; Cysteine proteases; Epilepsy; N myristoyltransferase; p53

Indexed keywords

CALCINEURIN; MYRISTOYLTRANSFERASE; PROTEIN BCL 2; PROTEIN N MYRISTOYLTRANSFERASE; PROTEIN P53; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; APOPTOSIS; BRAIN ISCHEMIA; BRAIN NERVE CELL; CHICKEN; COMPREHENSION; DRUG MECHANISM; EPILEPSY; HUMAN; MOLECULAR THERAPY; MOLECULE; NONHUMAN; PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW;

ACYLTRANSFERASES; ANIMALS; ANTICONVULSANTS; BRAIN; CALCINEURIN; DISEASE MODELS, ANIMAL; ENZYME INHIBITORS; EPILEPSY; HUMANS; SIGNAL TRANSDUCTION;

EID: 37249069585     PISSN: 03010082     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pneurobio.2007.09.004     Document Type: Review

References (68)

1. Ankarcrona M., Dypbukt J.M., Orrenius S., and Nicotera P. Calcineurin and mitochondrial function in glutamate-induced neuronal cell death. FEBS Lett. 394 (1996) 321-324
2. Arfin S.M., Kendall R.L., Hall L., Weaver L.H., Stewart A.E., and Matthews B.W. Eukaryotic methionine aminopeptidase: two classes of cobalt-dependent enzymes. Proc. Natl. Acad. Sci. U.S.A. 92 (1995) 7714-7718
3. Biswas S., Harris F., Dennison S., Singh J., and Phoenix D.A. Calpains: targets of cataract prevention?. Trends Mol. Med. 10 (2004) 78-84
4. Borlongan C.V., Emerich D.F., Hoffer B.J., and Bartus R.T. Bradykinin receptor agonist facilitates low-dose cyclosporine-A protection against 6-hydroxydopamine neurotoxicity. Brain Res. 956 (2002) 211-220
5. Burdette S.C., and Lippard S.J. Meeting of the minds: metalloneurochemistry. Proc. Natl Acad. Sci. U.S.A. 100 (2003) 3605-3610
6. Ekdahl C.T., Mohapel P., Weber E., Bahr B., Blomgren K., and Lindvall O. Caspase-mediated death of newly formed neurons in the adult rat dentate gyrus following status epilepticus. Eur. J. Neurosci. 16 (2002) 1463-1471
7. Erin N., and Billingsley M.L. Domoic acid enhances Bcl-2-calcineurin-inositol-1,4,5 trisphosphate receptor interactions and delayed neuronal death in rat brain slices. Brain Res. 1014 (2004) 45-52
8. Erin N., Bronson S.K., and Billingsley M.L. Calcium-dependent interaction of calcineurin with Bcl-2 in neuronal tissue. Neuroscience 117 (2003) 541-555
9. Farazi T.A., Waksman G., and Gordon J.I. The biology and enzymology of protein N-myristoylation. J. Biol. Chem. 276 (2001) 39501-39504
10. Freeland K., Boxer L.M., and Latchman D.S. The cyclic AMP response element in the Bcl-2 promoter confers inducibility by hypoxia in neuronal cells. Brain Res. Mol. Brain Res. 92 (2001) 98-106
11. Giang D.K., and Cravatt B.F. A second mammalian N-myristoyltransferase. J. Biol. Chem. 273 (1998) 6595-6598
12. Glover C.J., and Felsted R.L. Identification and characterization of multiple forms of bovine brain N-myristoyltransferase. J. Biol. Chem. 270 (1995) 23226-23233
13. Grant S.G., O'Dell T.J., Karl K.A., Stein P.L., Soriano P., and Kandel E.R. Impaired long-term potentiation, spatial learning, and hippocampal development in fyn mutant mice. Science 258 (1992) 1903-1910
14. Green D.R., and Reed J.C. Mitochondria and apoptosis. Science 281 (1998) 1309-1312
15. Henshall D.C., Clark R.S., Adelson P.D., Chen M., Watkins S.C., and Simon R.P. Alterations in bcl-2 and caspase gene family protein expression in human temporal lobe epilepsy. Neurology 55 (2000) 250-257
16. Isokawa M. N-methyl-d-aspartic acid-induced and Ca-dependent neuronal swelling and its retardation by brain-derived neurotrophic factor in the epileptic hippocampus. Neuroscience 131 (2005) 801-812
17. Jackson R., and Hunter T. Role of methionine in the initiation of haemoglobin synthesis. Nature 227 (1970) 672-676
18. Jayanthi S., Deng X., Ladenheim B., McCoy M.T., Cluster A., Cai N.S., and Cadet J.L. Calcineurin/NFAT-induced up-regulation of the Fas ligand/Fas death pathway is involved in methamphetamine-induced neuronal apoptosis. Proc. Natl Acad. Sci. U.S.A. 102 (2005) 868-873
19. Johnson D.D., Wilcox R., Tuchek J.M., and Crawford R.D. Experimental febrile convulsions in epileptic chickens: the anticonvulsant effect of elevated gamma-aminobutyric acid concentrations. Epilepsia 26 (1985) 466-471
20. Kalia L.V., Gingrich J.R., and Salter M.W. Src in synaptic transmission and plasticity. Oncogene 23 (2004) 8007-8016
21. Kaminska B., Figiel I., Pyrzynska B., Czajkowski R., and Mosieniak G. Treatment of hippocampal neurons with cyclosporin A results in calcium overload and apoptosis which are independent on NMDA receptor activation. Br. J. Pharmacol. 133 (2001) 997-1004
22. Kidd V.J., Lahti J.M., and Teitz T. Proteolytic regulation of apoptosis. Semin. Cell Dev. Biol. 11 (2000) 191-201
23. King M.J., and Sharma R.K. Demonstration of multiple forms of bovine brain myristoyl CoA:protein N-myristoyltransferase. Mol. Cell. Biochem. 113 (1992) 77-81
24. Kohr G., and Seeburg P.H. Subtype-specific regulation of recombinant NMDA receptor-channels by protein tyrosine kinases of the src family. J. Physiol. 492 (1996) 445-452
25. Kurz J.E., Sheets D., Parsons J.T., Rana A., Delorenzo R.J., and Churn S.B. A significant increase in both basal and maximal calcineurin activity in the rat pilocarpine model of status epilepticus. J. Neurochem. 78 (2001) 304-315
26. Lakshmikuttyamma A., Selvakumar P., Charavaryamath C., Singh B., Tuchek J., and Sharma R.K. Expression of calcineurin and its interacting proteins in epilepsy. J. Neurochem. 96 (2006) 366-373
27. Lakshmikuttyamma A., Selvakumar P., Sharma A.R., Anderson D.H., and Sharma R.K. In vitro proteolytic degradation of bovine brain calcineurin by m-calpain. Neurochem. Res. 29 (2004) 1913-1921
28. Lakshmikuttyamma A., Selvakumar P., Kakkar R., Kanthan R., Wang R., and Sharma R.K. Activation of calcineurin expression in ischemia-reperfused rat heart and in human ischemic myocardium. J. Cell. Biochem. 90 (2003) 987-997
29. Latinis K.M., Norian L.A., Eliason S.L., and Koretzky G.A. Two NFAT transcription factor binding sites participate in the regulation of CD95 (Fas) ligand expression in activated human T cells. J. Biol. Chem. 272 (1997) 31427-31434
30. 2+-dependent phosphatase. Nature 369 (1994) 235-239
31. Lu W.Y., Xiong Z.G., Lei S., Orser B.A., Dudek E., Browning M.D., and MacDonald J.F. G-protein-coupled receptors act via protein kinase C and Src to regulate NMDA receptors. Nat. Neurosci. 2 (1999) 331-338
32. Lu Y., Selvakumar P., Ali K., Shrivastav A., Bajaj G., Resch L., Griebel R., Fourney D., Meguro K., and Sharma R.K. Elevation in N-myristoyltransferase human brain tumor. Neurochem. Res. 30 (2005) 9-13
33. Lu Y.F., Tomizawa K., Moriwaki A., Hayashi Y., Tokuda M., Itano T., Hatase O., and Matsui H. Calcineurin inhibitors, FK506 and cyclosporin A, suppress the NMDA receptor-mediated potentials and LTP, but not depotentiation in the rat hippocampus. Brain Res. 729 (1996) 142-146
34. McIlhinney R.A., McGlone K., and Willis A.C. Purification and partial sequencing of myristoyl-CoA:protein N-myristoyltransferase from bovine brain. Biochem. J. 290 (1993) 405-410
35. 2+ homeostasis and disease. Cell Calcium 28 (2000) 1-21
36. Moia L.J., Matsui H., de Barros G.A., Tomizawa K., Miyamoto K., Kuwata Y., Tokuda M., Itano T., and Hatase O. Immunosuppressants and calcineurin inhibitors, cyclosporin A and FK506, reversibly inhibit epileptogenesis in amygdaloid kindled rat. Brain Res. 648 (1994) 337-341
37. Moon I.S., Apperson M.L., and Kennedy M.B. The major tyrosinephosphorylated protein in the postsynaptic density fraction is N-methyl-D-aspartate receptor subunit 2B. Proc. Natl. Acad. Sci. U.S.A. 91 (1994) 3954-3958
38. Morrison R.S., Kinoshita Y., Johnson M.D., Guo W., and Garden G.A. p53-dependent cell death signaling in neurons. Neurochem. Res. 28 (2003) 15-27
39. Narkilahti S., Nissinen J., and Pitkanen A. Administration of caspase 3 inhibitor during and after status epilepticus in rat: effect on neuronal damage and epileptogenesis. Neuropharmacology 44 (2003) 1068-1088
40. O'Dell T.J., Kandel E.R., and Grant S.G. Long-term potentiation in the hippocampus is blocked by tyrosine kinase inhibitors. Nature 353 (1991) 558-560
41. Pal S., Sombati S., Limbrick Jr. D.D., and DeLorenzo R.J. In vitro status epilepticus causes sustained elevation of intracellular calcium levels in hippocampal neurons. Brain Res. 851 (1999) 20-31
42. Pedder S.C., Wilcox R., Tuchek J.M., Johnson D.D., and Crawford R.D. The relationship between anticonvulsant activity and receptor affinity of N-methyl-d-aspartate antagonists in epileptic fowl. Neuropharmacology 28 (1989) 753-756
43. Raju R.V., Kakkar R., Datla R.S., Radhi J., and Sharma R.K. Myristoyl-coA, protein N-myristoyltransferase from bovine cardiac muscle, molecular cloning, kinetic analysis, and in vitro proteolytic cleavage by m-calpain. Exp. Cell. Res. 241 (1998) 23-35
44. Resh M.D. Fatty acylation of proteins: new insights into membrane targeting of myristoylated and palmitoylated proteins. Biochim. Biophys. Acta 1451 (1999) 1-16
45. 2+: their relationship to apoptosis and oncogenesis. FEBS Lett. 325 (1993) 104-107
46. Sakhi S., Bruce A., Sun N., Tocco G., Baudry M., and Schreiber S.S. p53 induction is associated with neuronal damage in the central nervous system. Proc. Natl Acad. Sci. U.S.A. 91 (1994) 7525-7529
47. Sandirasegarane L., Mikler J.R., Tuchek J.M., and Sulakhe P.V. Enhanced forebrain nitric oxide synthase activity in epileptic fowl. Brain Res. 735 (1996) 311-313
48. Sanna P.P., Berton F., Cammalleri M., Tallent M.K., Siggins G.R., Bloom F.E., and Francesconi W. A role for Src kinase in spontaneous epileptiform activity in the CA3 region of the hippocampus. Proc. Natl. Acad. Sci. U.S.A. 97 (2000) 8653-8657
49. Selvakumar P., Lakshmikuttyamma A., Shrivastav A., Das S.B., Dimmock J.R., and Sharma R.K. Potential role of N-myristoyltransferase in cancer. Prog. Lipid Res. 46 (2007) 1-36
50. Selvakumar P., Lakshmikuttyamma A., Dimmock J.R., and Sharma R.K. Methionine aminopeptidase 2 and cancer. Biochim. Biophys. Acta 1765 (2006) 148-154
51. Selvakumar P., Smith-Windsor E., Bonham K., and Sharma R.K. N-myristoyltransferase 2 expression in human colon cancer: cross-talk between the calpain and caspase system. FEBS Lett. 580 (2006) 2021-2026
52. Selvakumar P., Lakshmikuttyamma A., Charavaryamath C., Singh B., Tuchek J., and Sharma R.K. Expression of myristoyltransferase and its interacting proteins in epilepsy. Biochem. Biophys. Res. Commun. 335 (2005) 1132-1139
53. Selvakumar P., Lakshmikuttyamma A., Pasha M.K., King M.J., Olson D.J., Mori S., Ross A.R., Hayashi K., Dimmock J.R., and Sharma R.K. N-myristoyltransferase inhibitor protein is homologous to heat shock cognate protein 70. J. Cell. Biochem. 92 (2004) 573-578
54. Selvakumar P., Lakshmikuttyamma A., Kanthan R., Kanthan S.C., Dimmock J.R., and Sharma R.K. High expression of methionine aminopeptidase 2 in human colorectal adenocarcinomas. Clin. Cancer Res. 10 (2004) 2771-2775
55. Selvakumar P., Lakshmikuttyamma A., Lawman Z., Bonham K., Dimmock J.R., and Sharma R.K. Expression of methionine aminopeptidase 2, N-myristoyltransferase, and N-myristoyltransferase inhibitor protein 71 in HT29. Biochem. Biophys. Res. Commun. 322 (2004) 1012-1017
56. Selvakumar P., Pasha M.K., Ashakumary L., Dimmock J.R., and Sharma R.K. Myristoyl-CoA:protein N-myristoyltransferase: a novel molecular approach for cancer therapy. Int. J. Mol. Med 10 (2002) 493-500
57. Shibasaki F., Kondo E., Akagi T., and McKeon F. Suppression of signalling through transcription factor NF-AT by interactions between calcineurin and Bcl-2. Nature 386 (1997) 728-731
58. Suzuki F., Heinrich C., Boehrer A., Mitsuya K., Kurokawa K., Matsuda M., and Depaulis A. Glutamate receptor antagonists and benzodiazepine inhibit the progression of granule cell dispersion in a mouse model of mesial temporal lobe epilepsy. Epilepsia 46 (2005) 193-202
59. Tan Z., Sankar R., Tu W., Shin D., Liu H., Wasterlain C.G., and Schreiber S.S. Immunohistochemical study of p53-associated proteins in rat brain following lithium-pilocarpine status epilepticus. Brain Res. 929 (2002) 129-138
60. Tezuka T., Umemori H., Akiyama T., Nakanishi S., and Yamamoto T. PSD-95 promotes Fyn-mediated tyrosine phosphorylation of the N-methyl-D-aspartate receptor subunit NR2A. Proc. Natl. Acad. Sci. U.S.A. 96 (1999) 435-440
61. Tsuchiya D., Hong S., Matsumori Y., Kayama T., Swanson R.A., Dillman W.H., Liu J., Panter S.S., and Weinstein P.R. Overexpression of rat heat shock protein 70 reduces neuronal injury after transient focal ischemia, transient global ischemia, or kainic acid-induced seizures. Neurosurgery 53 (2003) 1179-1187
62. Vanderklish P.W., and Bahr B.A. The pathogenic activation of calpain: a marker and mediator of cellular toxicity and disease states. Int. J. Exp. Pathol. 81 (2000) 323-339
63. Wang T., Yu X.M., and Salter M.W. Ca(2+)-independent reduction of N-methyl-D-aspartate channel activity by protein tyrosine phosphatase. Proc. Natl. Acad. Sci. U.S.A. 93 (1996) 1721-1725
64. Wera S., and Neyts J. Calcineurin as a possible new target for treatment of Parkinson's disease. Med. Hypotheses 43 (1994) 132-134
65. White B.C., Sullivan J.M., DeGracia D.J., O'Neil B.J., Neumar R.W., Grossman L.I., Rafols J.A., and Krause G.S. Brain ischemia and reperfusion: molecular mechanisms of neuronal injury. J. Neurol. Sci. 179 (2000) 1-33
66. Yagi T. Molecular mechanisms of Fyn-tyrosine kinase for regulating mammalian behaviors and ethanol sensitivity. Biochem. Pharmacol. 57 (1999) 845-850
67. Yenari M.A. Heat shock proteins and neuroprotection. Adv. Exp. Med. Biol. 513 (2002) 281-299
68. Yu X.M., Askalan R., Keil 2nd G.J., and Salter M.W. NMDA channel regulation by channel-associated protein tyrosine kinase Src. Science 275 (1997) 674-678